Literature DB >> 6088572

Factors influencing quantitative isolation of varicella-zoster virus.

M J Levin, S Leventhal, H A Masters.   

Abstract

Optimal conditions are described for the recovery of cell culture-derived varicella-zoster virus (VZV). Of the cells tested, human embryonic lung fibroblasts were the most sensitive. Storage and handling procedures were examined to determine the stability of VZV in viral transport medium. When the initial VZV titer was high (2 X 10(4) PFU/ml) 40% of the VZV survived room temperature for 24 h and 75% of the VZV remained viable for this long at 4 degrees C. Recovery was 5- to 10-fold less at lower initial VZV titers (less than 2 X 10(3) PFU/ml). Other factors which influenced VZV recovery included freezing at -20 degrees C, the use of cotton or calcium alginate swabs, and filtration to remove bacterial contaminants. The tissue culture methods described were used in a reconstruction experiment to demonstrate that VZV could be recovered from a laboratory coat or human skin (0.1 to 0.3% of input VZV) or from a stethoscope (19% of input VZV) as late as 30 min after inoculation. During a clinical trial using optimal VZV recovery procedures, 76% of the patients with herpes zoster yielded VZV when first cultured, and 60% remained culture positive for an additional 48 h.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6088572      PMCID: PMC271203          DOI: 10.1128/jcm.19.6.880-883.1984

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

1.  Incubation of swab materials with herpes simplex virus.

Authors:  L R Crane; P A Gutterman; T Chapel; A M Lerner
Journal:  J Infect Dis       Date:  1980-04       Impact factor: 5.226

2.  Evaluation of therapeutic efficacy of amantadine in patients with naturally occurring A2 influenza.

Authors:  Y Togo; R B Hornick; V J Felitti; M L Kaufman; A T Dawkins; V E Kilpe; J L Claghorn
Journal:  JAMA       Date:  1970-02-16       Impact factor: 56.272

3.  The role of temperature and swab materials in the recovery of herpes simplex virus from lesions.

Authors:  E J Bettoli; P M Brewer; M J Oxtoby; A A Zaidi; M E Guinan
Journal:  J Infect Dis       Date:  1982-03       Impact factor: 5.226

4.  Shedding and survival of herpes simplex virus from 'fever blisters'.

Authors:  R Turner; Z Shehab; K Osborne; J O Hendley
Journal:  Pediatrics       Date:  1982-10       Impact factor: 7.124

5.  Multicenter collaborative trial of intravenous acyclovir for treatment of mucocutaneous herpes simplex virus infection in the immunocompromised host.

Authors:  J D Meyers; J C Wade; C D Mitchell; R Saral; P S Lietman; D T Durack; M J Levin; A C Segreti; H H Balfour
Journal:  Am J Med       Date:  1982-07-20       Impact factor: 4.965

6.  Mucocutaneous herpes simplex virus infections in immunocompromised patients. A model for evaluation of topical antiviral agents.

Authors:  R Whitley; N Barton; E Collins; J Whelchel; A G Diethelm
Journal:  Am J Med       Date:  1982-07-20       Impact factor: 4.965

7.  Acyclovir therapy for mucocutaneous herpes simplex infections in immunocompromised patients.

Authors:  C D Mitchell; B Bean; S R Gentry; K E Groth; J R Boen; H H Balfour
Journal:  Lancet       Date:  1981-06-27       Impact factor: 79.321

8.  Early vidarabine therapy to control the complications of herpes zoster in immunosuppressed patients.

Authors:  R J Whitley; S J Soong; R Dolin; R Betts; C Linnemann; C A Alford
Journal:  N Engl J Med       Date:  1982-10-14       Impact factor: 91.245

9.  Treatment of first episodes of genital herpes simplex virus infection with oral acyclovir. A randomized double-blind controlled trial in normal subjects.

Authors:  Y J Bryson; M Dillon; M Lovett; G Acuna; S Taylor; J D Cherry; B L Johnson; E Wiesmeier; W Growdon; T Creagh-Kirk; R Keeney
Journal:  N Engl J Med       Date:  1983-04-21       Impact factor: 91.245

10.  Intravenous acyclovir to treat mucocutaneous herpes simplex virus infection after marrow transplantation: a double-blind trial.

Authors:  J C Wade; B Newton; C McLaren; N Flournoy; R E Keeney; J D Meyers
Journal:  Ann Intern Med       Date:  1982-03       Impact factor: 25.391

View more
  5 in total

1.  Simultaneous seeding and infecting of shell vials for rapid detection of cytomegalovirus infection.

Authors:  M J Espy; T F Smith
Journal:  J Clin Microbiol       Date:  1987-05       Impact factor: 5.948

2.  Homotypic Dengue Virus Reinfections in Nicaraguan Children.

Authors:  Jesse J Waggoner; Angel Balmaseda; Lionel Gresh; Malaya K Sahoo; Magelda Montoya; Chunling Wang; Janaki Abeynayake; Guillermina Kuan; Benjamin A Pinsky; Eva Harris
Journal:  J Infect Dis       Date:  2016-03-16       Impact factor: 5.226

Review 3.  Varicella-zoster virus.

Authors:  A M Arvin
Journal:  Clin Microbiol Rev       Date:  1996-07       Impact factor: 26.132

4.  Simultaneous detection of and differentiation between herpes simplex and varicella-zoster viruses with two fluorescent probes in the same test system.

Authors:  B G Brumback; P G Farthing; S N Castellino
Journal:  J Clin Microbiol       Date:  1993-12       Impact factor: 5.948

Review 5.  Rapid and accurate viral diagnosis.

Authors:  M L Landry; D R Mayo; G D Hsiung
Journal:  Pharmacol Ther       Date:  1989       Impact factor: 12.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.